FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

764843001: Powder for conventional release solution for infusion (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3655272013 Powder for conventional release solution for infusion (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3655273015 Powder for conventional release solution for infusion en Synonym Active Entire term case insensitive SNOMED CT core module
3655274014 Powder for solution for infusion en Synonym Active Entire term case insensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for conventional release solution for infusion Is a Parenteral dose form false Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion Has dose form administration method Infuse true Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion Has dose form transformation Dissolve true Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion Has basic dose form Powder true Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion Is a Powder for conventional release solution for infusion and/or injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Streptokinase 1.5million iu powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Streptokinase 250,000iu powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Streptokinase 750,000iu powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Cefotaxime 2g powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Imipenem 500mg/cilastatin 500mg powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Amphotericin 100mg powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Cisplatin 50mg powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Vancomycin hydrochloride 10g powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Erythromycin lactobionate 500mg powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Erythromycin lactobionate 1g powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely drotrecogin alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Ertapenem 1g powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Drotrecogin alfa (activated) 5mg powder for infusion solution vial Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Vancomycin hydrochloride 750mg powder for infusion solution Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Gemcitabine 2g powder for infusion solution Has manufactured dose form False Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for infusion Is a True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely aciclovir (as aciclovir sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely blinatumomab 38.5 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely belatacept 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely rabbit anti-human T-lymphocyte globulin 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely anidulafungin 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely alglucosidase alfa 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely epoprostenol (as epoprostenol sodium) 1.5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely dacarbazine (as dacarbazine citrate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely dacarbazine (as dacarbazine citrate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely dexrazoxane (as dexrazoxane hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely decitabine 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely clarithromycin (as clarithromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 150 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Powder for conventional release solution for infusion or injection Is a True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely caspofungin (as caspofungin acetate) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely caspofungin (as caspofungin acetate) 70 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely normal human immunoglobulin 10 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 400 milligram/1 bag powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely tasonermin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trabectedin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab 420 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely isavuconazole (as isavuconazonium sulfate) 200 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Product containing precisely lenograstim 33.6 million unit/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Meropenem 1g / Vaborbactam 1g powder for solution for infusion vials Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Meropenem 1g / Vaborbactam 1g powder for solution for infusion vials 6 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Vaborem 1g/1g powder for concentrate for solution for infusion vials (A. Menarini Farmaceutica Internazionale SRL) Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Vaborem 1g/1g powder for concentrate for solution for infusion vials (A. Menarini Farmaceutica Internazionale SRL) 6 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Polivy 30mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Polivy 30mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Polatuzumab vedotin 140mg powder for solution for infusion vials 1 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan 100mg powder for solution for infusion vials Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Trastuzumab 60mg powder for solution for infusion vials Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Oritavancin 400mg powder for solution for infusion vials Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Sacituzumab govitecan 180mg powder for solution for infusion vials Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Olipudase alfa 20mg powder for solution for infusion vials Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) 1 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan 100mg powder for solution for infusion vials 1 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier
Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) Has dispensed dose form True Powder for conventional release solution for infusion Inferred relationship Existential restriction modifier

Page 1 of 14 Next End

This concept is not in any reference sets

Back to Start